Abstract

We developed a novel optical molecular specific contrast agent that targets vascular endothelial growth factor (VEGF). We tested the agent in mouse tumor models and detected increased VEGF expression in vivo following cobalt chloride treatment.

© 2006 Optical Society of America

PDF Article